Police are investigating after a burglary in Ulverston.
The break-in took place last night (21 November) at the Co-Operative store on Priory Lane.
The offenders forces their way into the store, taking cigarettes, alcohol and an amount of cash. They also attempted to force open a cash machine, destroyed CCTV camera's and the stories alarm system.
This incident follows numerous other incidents in South Cumbria.
Thursday 7 November - wires outside the Co-Operative Insurance store on The Square, Hawkshead were cut before those responsible forced themselves into the shop, damaging the internal alarm system
Tuesday 19 November - offenders have cut the telephone wire outside the Co-Operative Travel store on Kents Bank Road, Grange-over-Sands before entering and damaging the alarm systems. No property was taken.
Tuesday 19 November - telephone wires linking to Flookburgh Post Office on Market Street were cut. No other damage was caused and the Post Office was not broken into.
Police believe these cases to be linked and are appealing to anyone with information about them to contact them on the 101 number and ask for Barrow CID.
GSK today confirmed that it will invest more than £500m in the UK across its manufacturing sites to increase production of key active ingredients for its pharmaceutical products and vaccines.
The company announced selection of Ulverston in Cumbria as the location for the first new GSK manufacturing facility to be built in the UK for almost 40 years.
In total more than £500m of investment confirmed, creating up to 1,000 new jobs.
Includes £100m investment for GSK manufacturing in Scotland.
The introduction of the patent box has transformed the way in which we view the UK as a location for new investments, ensuring that the medicines of the future will not only be discovered, but can also continue to be made here in Britain. Consequently, we can confirm that we will build GSK’s first new UK factory for almost 40 years and that we will make other substantial capital investments in our British manufacturing base. In total, this will create up to 1,000 new jobs over the lifetime of the projects.
– Sir Andrew Witty, Chief Executive, GSK
Investment will also be made at the company’s two manufacturing sites in Scotland at Montrose and Irvine. In total, it is anticipated these investments will create up to 1,000 new jobs over the lifetime of the projects.